首页> 外国专利> antibody or binding fragment, sequence no: 3 or sequence no: 7, antibody-drug conjugate (adc), pharmaceutical composition, process for producing the pharmaceutical composition, kit for diagnosing an individual suffering from a neurodegenerative disorder, method to diagnose an individual suffering from a neurodegenerative disorder, use of antibody or binding fragment, ex vivo use of a t14 peptide, method of identifying a candidate agent, method of identifying an agent, method of identifying a modulating agent

antibody or binding fragment, sequence no: 3 or sequence no: 7, antibody-drug conjugate (adc), pharmaceutical composition, process for producing the pharmaceutical composition, kit for diagnosing an individual suffering from a neurodegenerative disorder, method to diagnose an individual suffering from a neurodegenerative disorder, use of antibody or binding fragment, ex vivo use of a t14 peptide, method of identifying a candidate agent, method of identifying an agent, method of identifying a modulating agent

机译:抗体或结合片段,序列号:3或序列号:7,抗体-药物偶联物(adc),药物组合物,制备药物组合物的方法,用于诊断患有神经退行性疾病的个体的试剂盒,诊断个体患病的方法来自神经退行性疾病,抗体或结合片段的使用,t14肽的离体使用,鉴定候选药物的方法,鉴定药物的方法,鉴定调节剂的方法

摘要

The invention relates to antibodies, and in particular to antibodies used in the diagnosis and treatment of neurodegenerative disorders, such as alzheimer's disease and parkinson's disease. The invention extends to methods of diagnosis and therapy of neurodegenerative disorders, and to assays and screenings for isolating novel therapeutic compounds.
机译:本发明涉及抗体,尤其涉及用于神经退行性疾病例如阿尔茨海默氏病和帕金森氏病的诊断和治疗的抗体。本发明涉及神经退行性疾病的诊断和治疗方法,以及分离新的治疗化合物的测定和筛选。

著录项

  • 公开/公告号BR112017020769A2

    专利类型

  • 公开/公告日2018-06-26

    原文格式PDF

  • 申请/专利权人 NEURO-BIO LTD;

    申请/专利号BR20171120769

  • 申请日2016-03-23

  • 分类号C07K16/40;

  • 国家 BR

  • 入库时间 2022-08-21 12:53:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号